Related references
Note: Only part of the references are listed.Management of polypoidal choroidal vasculopathy: Experts consensus in Taiwan
Lee-Jen Chen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Pravin U. Dugel et al.
OPHTHALMOLOGY (2020)
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study
Richard P. Gale et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52-and 96-Week Findings from ALTAIR A Randomized Controlled Trial
Masahito Ohji et al.
ADVANCES IN THERAPY (2020)
Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration
Adam H. Ross et al.
EYE (2020)
Hyperreflective foci in predicting the treatment outcome of antivascular endothelial growth factor in neovascular age-related macular degeneration
Yun Hsia et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)
Three-Year Outcomes of Patients with Neovascular Age-Related Macular Degeneration Treated with Aflibercept under the National Health Insurance Program in Taiwan
Kang-Jung Lo et al.
JOURNAL OF OPHTHALMOLOGY (2020)
EXIT STRATEGY IN A TREAT-AND-EXTEND REGIMEN FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Petra Arendt et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)
Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study
Tso-Ting Lai et al.
SCIENTIFIC REPORTS (2019)
Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial
Mark C. Gillies et al.
JAMA OPHTHALMOLOGY (2019)
Prevalence of age-related macular degeneration in Chinese populations worldwide: A systematic review and meta-analysis
Guangming Jin et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Priority options of anti-vascular endothelial growth factor agents in wet age-related macular degeneration under the National Health Insurance Program
Yu-Bai Chou et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)
Real-world outcomes of intravitreal antivascular endothelial growth factors for neovascular age-related macular degeneration in Taiwan: A 4-year longitudinal study
Benjamin Chi-Lan Yang et al.
TAIWAN JOURNAL OF OPHTHALMOLOGY (2019)
ANGIOGRAPHIC SUBTYPES OF POLYPOIDAL CHOROIDAL VASCULOPATHY IN TAIWAN A Prospective Multicenter Study
Ling Yeung et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)
Recurrence Rate of Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration Managed with a Treat-Extend-Stop Protocol
Sean D. Adrean et al.
OPHTHALMOLOGY RETINA (2018)
The burden of neovascular age-related macular degeneration: a patient's perspective
Kimberly L. Spooner et al.
CLINICAL OPHTHALMOLOGY (2018)
Treatment of age-related neovascular macular degeneration: the patient's perspective
S. Mueller et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2017)
Advanced quantitative analysis of the sub-retinal pigment epithelial space in recurrent neovascular age-related macular degeneration
Mariko Sasaki et al.
PLOS ONE (2017)
Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
Kimberly Spooner et al.
CLINICAL OPHTHALMOLOGY (2017)
Characteristics and Predictors of Early and Delayed Responders to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Retrospective Analysis from the ANCHOR, MARINA, HARBOR, and CATT Trials
Richard Gale et al.
OPHTHALMOLOGICA (2016)
Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2016)
Patient Preferences in the Treatment of Neovascular Age-Related Macular Degeneration A Discrete Choice Experiment
Sabrina Mueller et al.
OPHTHALMOLOGY (2016)
Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials
Sebastian M. Waldstein et al.
OPHTHALMOLOGY (2016)
Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials
Sumit Sharma et al.
OPHTHALMOLOGY (2016)
Risk factors and biomarkers of age-related macular degeneration
Nathan G. Lambert et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2016)
Understanding the patient's lived experience of neovascular age-related macular degeneration: a qualitative study
C. McCloud et al.
EYE (2015)
Defining response to anti-VEGF therapies in neovascular AMD
W. M. Amoaku et al.
EYE (2015)
Scheduled versus Pro Re Nata Dosing in the VIEW Trials
Gisbert Richard et al.
OPHTHALMOLOGY (2015)
Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials
Alex S. Willoughby et al.
OPHTHALMOLOGY (2015)
Pigment Epithelial Detachment Followed by Retinal Cystoid Degeneration Leads to Vision Loss in Treatment of Neovascular Age-Related Macular Degeneration
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2015)
Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT)
Gui-shuang Ying et al.
OPHTHALMOLOGY (2015)
Optimizing the Anti-VEGF Treatment Strategy for Neovascular Age-Related Macular Degeneration: From Clinical Trials to Real-Life Requirements
Irmela Mantel
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2015)
Association between Neovascular Age-Related Macular Degeneration and Dementia: A Population-Based Case-Control Study in Taiwan
Shiu-Dong Chung et al.
PLOS ONE (2015)
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
Ursula Schmidt-Erfurth et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Prevalence and risk factors for age-related macular degeneration in the elderly Chinese population in south-western Taiwan: the Puzih eye study
E. J-C Huang et al.
EYE (2014)
Relationship between Visual Acuity and Spectral Domain Optical Coherence Tomography Retinal Parameters in Neovascular Age-Related Macular Degeneration
Tina Ristau et al.
OPHTHALMOLOGICA (2014)
Morphologic Parameters Relevant for Visual Outcome During Anti-Angiogenic Therapy of Neovascular Age-Related Macular Degeneration
Christian Simader et al.
OPHTHALMOLOGY (2014)
THE PEARL NECKLACE SIGN A Novel Spectral Domain Optical Coherence Tomography Finding in Exudative Macular Disease
Susan K. Gelman et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
Wan Ling Wong et al.
LANCET GLOBAL HEALTH (2014)
Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment
Sara B. Bloch et al.
ACTA OPHTHALMOLOGICA (2013)
Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial
Laurent Kodjikian et al.
OPHTHALMOLOGY (2013)
Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration
Gui-shuang Ying et al.
OPHTHALMOLOGY (2013)
Clinical Classification of Age-related Macular Degeneration
Frederick L. Ferris et al.
OPHTHALMOLOGY (2013)
ANATOMICAL MEASURES AS PREDICTORS OF VISUAL OUTCOMES IN RANIBIZUMAB-TREATED EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
David M. Brown et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Prevalence and causes of visual impairment in elderly Amis aborigines in eastern Taiwan (the Amis Eye Study)
Nancy Chen et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Results of flexible ranibizumab treatment in age-related macular degeneration and search for parameters with impact on outcome
Heinrich Gerding et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
Frank G. Holz et al.
OPHTHALMOLOGY (2011)
Quantification of the Therapeutic Response of Intraretinal, Subretinal, and Subpigment Epithelial Compartments in Exudative AMD during Anti-VEGF Therapy
Isabelle Golbaz et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
The Prevalence of Age-Related Macular Degeneration in Asians A Systematic Review and Meta-Analysis
Ryo Kawasaki et al.
OPHTHALMOLOGY (2010)
Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
David M. Brown et al.
OPHTHALMOLOGY (2009)
PREDICTORS OF ANTI-VEGF-ASSOCIATED RETINAL PIGMENT EPITHELIAL TEAR USING FA AND OCT ANALYSIS
Allen Chiang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: The Shihpai Eye Study
Shih-Jen Chen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration
Anne E. Fung et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8
A Kassoff et al.
ARCHIVES OF OPHTHALMOLOGY (2001)
Risk factors for age related macular degeneration -: Pooled findings from three continents
W Smith et al.
OPHTHALMOLOGY (2001)
Share Paper
